While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal

While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal

Source: 
Endpoints
snippet: 

British prime minister Theresa May’s draft divorce deal from the European Union has spurred hoots of derision from her growing ranks of critics in the UK, but the hard-fought and controversial agreement has met with cautious optimism from the trade association representing the biopharma and lifesciences industry in the United Kingdom.